NCD Immuno-Pharma Private Limited
About NCD Immuno-Pharma Private Limited
Data last updated:
NCD Immuno-Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB2022PTC252589. Its GSTIN is 19AAICN1517G1ZI (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Sandip Kumar Goswami (Managing Director) and Arijit Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 501 5th Floor 'Sri Sai Plaza' Building 89 A.J.C. Bose Road, Kolkata, West Bengal, India – 700014.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.74 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹6.94 Lakh (net margin 10.4%) and EBITDA of ₹9.47 Lakh (EBITDA margin 14.2%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRoom No. 501 5th Floor 'Sri Sai Plaza' Building 89 A.J.C. Bose Road, Kolkata, West Bengal, India – 700014
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of NCD Immuno-Pharma Private Limited
The main business activity of NCD Immuno-Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of NCD Immuno-Pharma Private Limited
NCD Immuno-Pharma Private Limited is audited by AKD & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AKD & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of NCD Immuno-Pharma Private Limited
NCD Immuno-Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arijit Das | Director | 29 Mar 2022 | 4 Years 6 Months | Current |
| Sandip Kumar Goswami | Managing Director | 29 Mar 2022 | 4 Years 6 Months | Current |
Financials of NCD Immuno-Pharma Private Limited FY 2025 filings available
NCD Immuno-Pharma Private Limited reported revenue of ₹66.74 Lakh (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of NCD Immuno-Pharma Private Limited
Revenue rose 15% in the latest year. EBITDA rose 150% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of NCD Immuno-Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.47 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.94 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of NCD Immuno-Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 14.2% | •••• | •••• | •••• |
| Net Profit Margin | 10.4% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of NCD Immuno-Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of NCD Immuno-Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of NCD Immuno-Pharma Private Limited
NCD Immuno-Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at NCD Immuno-Pharma Private Limited
NCD Immuno-Pharma Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of NCD Immuno-Pharma Private Limited
NCD Immuno-Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAICN1517G1ZI | West Bengal | Active | 09 Oct 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for NCD Immuno-Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by NCD Immuno-Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of NCD Immuno-Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of NCD Immuno-Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on NCD Immuno-Pharma Private Limited
Frequently Asked Questions about NCD Immuno-Pharma Private Limited
NCD Immuno-Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 March 2022 (4+ years old) and is registered under CIN U24231WB2022PTC252589.
NCD Immuno-Pharma reported revenue of ₹66.74 Lakh for FY 2025 (up 15% YoY).
NCD Immuno-Pharma has 2 current directors:
- Sandip Kumar Goswami - Managing Director
- Arijit Das - Director
NCD Immuno-Pharma reported a net profit of ₹6.94 Lakh (net margin 10.4%) and EBITDA of ₹9.47 Lakh (EBITDA margin 14.2%) for FY 2025, as per its filed financial statements.
The GSTIN of NCD Immuno-Pharma is 19AAICN1517G1ZI, registered in West Bengal.
The CIN (Corporate Identification Number) of NCD Immuno-Pharma is U24231WB2022PTC252589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NCD Immuno-Pharma was incorporated on 29 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
The registered office of NCD Immuno-Pharma is at Room No. 501 5th Floor Sri Sai Plaza Building 89 A.J.C. Bose Road, Kolkata, West Bengal, India – 700014.
NCD Immuno-Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh.